ARTICLE | Company News
Bind Biosciences board of directors update
September 24, 2012 7:00 AM UTC
Bind Biosciences Inc., Cambridge, Mass. Business: Cancer, Drug delivery Appointed: Daniel Lynch as chairman, formerly CEO and CFO of ImClone Systems Inc., which Eli Lilly and Co. acquired ...